Medscape Perspectives on the American Psychiatric Association (APA) 60th Institute on Psychiatric Services
October 2 - 5, 2008, Chicago, Illinois
This activity is not sanctioned by, nor a part of, the American Psychiatric Association. Conference news does not receive grant support and is produced independently.
Patients Welcome Telepsychiatry Approach to Depression TreatmentA new telemedicine group therapy protocol, currently in the developmental phase, was evaluated favorably by patients with epilepsy and depression. If it is successful, researchers believe this type of remote treatment could be used to reach much larger numbers of psychiatric patients.
Medscape Medical News, October 15, 2008
Allergy to Antipsychotics Often a False DiagnosisNew research shows fewer than 10% of patients with pharmacy records listing an allergy to antipsychotics actually had a true allergy, a finding that suggests drug-treatment options might be needlessly limited by this false assessment.
Medscape Medical News, October 10, 2008
Frequent Mental Distress Reported by 1 in 10 AmericansNew research by the Centers for Disease Control and Prevention shows, on average, that approximately 10% of adults in the United States report that they have frequent mental distress.
Medscape Medical News, October 8, 2008
No Negative Impact of ADHD Drug on Adults' Cardiovascular Function, Sleep PatternsSafety data from a study of the central nervous system stimulant lisdexamfetamine dimesylate show the drug is safe for the treatment of attention-deficit hyperactivity disorder in otherwise-healthy adults, with no major negative effects on the heart or sleep patterns.
Medscape Medical News, October 8, 2008
Obese African American Women More Likely to Be DepressedAfrican American women who are obese are 41% more likely than their slimmer counterparts to be depressed, according to new research from the Centers for Disease Control and Prevention.
Medscape Medical News, October 6, 2008
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Psychiatric Association. These materials and the related activity are not sanctioned by the American Psychiatric Association or the commercial supporter of the conference and do not constitute an official part of that conference.
